Reply to P.F. Pinsky, C.P. Crum, and M.W. McIntosh et al
J Clin Oncol
.
2016 Jan 10;34(2):201-2.
doi: 10.1200/JCO.2015.64.1365.
Epub 2015 Nov 16.
Authors
Usha Menon
1
,
Jatinderpal K Kalsi
2
,
Aleksandra Gentry-Maharaj
2
,
Andy Ryan
2
,
Matthew Burnell
2
,
Max Parmar
2
,
Lesley Fallowfield
3
,
Stuart Campbell
4
,
Alistair McGuire
5
,
Steven Skates
6
,
Ian Jacobs
7
Affiliations
1
University College London, London, United Kingdom u.menon@ucl.ac.uk.
2
University College London, London, United Kingdom.
3
University of Sussex, Falmer, United Kingdom.
4
Create Health Clinic, London, United Kingdom.
5
London School of Economics, London, United Kingdom.
6
Massachusetts General Hospital and Harvard Medical School, Boston, MA.
7
University College London, London, United Kingdom; and University of New South Wales, Sydney, New South Wales, Australia.
PMID:
26573079
DOI:
10.1200/JCO.2015.64.1365
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Biomarkers, Tumor / blood*
Early Detection of Cancer / methods*
Female
Humans
Ovarian Neoplasms / blood*
Substances
Biomarkers, Tumor
Grants and funding
G9901012/MRC_/Medical Research Council/United Kingdom
DH_/Department of Health/United Kingdom
CRUK_/Cancer Research UK/United Kingdom
G0000735/MRC_/Medical Research Council/United Kingdom
G0801228/MRC_/Medical Research Council/United Kingdom